“I want to get better, but...”
Identifying the perceptions and experiences of people who inject drugs with respect to evolving hepatitis C virus treatments
Datos Bibliográficos
| ID | 17760331 |
|---|---|
| Autores | Trevor Goodyear (0000-0002-7068-575X, British Columbia Centre on Substance Use, autor de correspondencia), Helen Brown (0000-0002-1095-5148, University of British Columbia), Helen Viola Brown (0000-0001-7026-0455), A Browne (0000-0002-6320-4428, University of British Columbia), Peter Hoong (British Columbia Centre on Substance Use), Lianping Ti (0000-0003-2470-438X, University of British Columbia), Rod Knight (0000-0002-1464-1584, British Columbia Centre on Substance Use) |
| Año | 2021 |
| Volumen | 20 |
| Número | 1 |
| Páginas | 81-81 |
| Fecha de publicación | 2021-03-19 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | International Journal for Equity in Health (JOURNAL) |
| Identificadores de la revista | ISSN: 1475-9276 • E-ISSN: 1475-9276 |
| Editorial | BioMed Central (PUBLISHER • GB) |
| DOI | 10.1186/s12939-021-01420-7 |
| PMID | 33740984 |
| OpenAlex | W3127305550 |
| Idioma | EN |
| Citas recibidas | 7 |
| Referencias citadas | 70 |
These findings underscore several equity-oriented healthcare service delivery and clinician adaptations that are required to scale up DAAs among PWID living with HCV, including the provision of harm reduction-focused, non-stigmatizing, integrated, and peer-led care that responds to power differentials
Environmental health · Family medicine · Gatekeeping · Health administration · Health care · Health services research · Hepatitis C · Hepatitis C virus · Population · Public health · Virus · Hepatitis B Virus Studies · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Medicine · Nursing · Internal Medicine · Virology
Client resistance to hepatitis C treatment initiation in opioid agonist treatment clinics in Sydney, Australia
HIV and hepatitis C virus-related misinformation may contribute to rising rates of infection and suboptimal clinical outcomes among persons with substance use
Accessing hepatitis C direct acting antivirals among people living with hepatitis C
Reinfection following successful direct-acting antiviral therapy for HCV infection among people attending an inner-city community health centre in Victoria, Canada
Using nominal group technique (NGT) to identify barriers and facilitators to implement rapid-start direct-acting antiviral (DAA) for people who use drugs living with hepatitis C in Malaysia
Not just one box that you tick off’ – Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective
Apparently, you can only be treated once”
Enhancing health care equity with Indigenous populations
Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs
Hepatitis C treatment access and uptake for people who inject drugs
Global prevalence and genotype distribution of hepatitis C virus infection in 2015
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs
Purposeful Sampling for Qualitative Data Collection and Analysis in Mixed Method Implementation Research
Canadian Drug Policy and the Reproduction of Indigenous Inequities
Shifting moral values to enhance access to health care
Deviant Constructions
Disruption as opportunity
Another thing to live for”
Everybody living with a chronic disease is entitled to be cured”
Integrating hepatitis C and addiction care for people who inject drugs in the era of direct-acting antiviral therapy
Supervised injection facility use and exposure to violence among a cohort of people who inject drugs
Elimination of hepatitis C virus infection among PWID
Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals
Initiating HCV treatment with direct acting agents in opioid agonist treatment
Homelessness, drug use and Hepatitis C
Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countries
Individual and network factors associated with HCV treatment uptake among people who inject drugs
Conceptualising access in the direct-acting antiviral era
Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting
Knowledge of hepatitis C and treatment willingness amongst people who inject drugs in an era of direct acting antivirals
Interventions and approaches to integrating HIV and mental health services
Will peer-based interventions improve hepatitis C virus treatment uptake among young people who inject drugs
The successful scale-up of direct-acting antiviral hepatitis C treatments will benefit from concerted investments in implementation science
Moving beyond description
Taming systems to create enabling environments for HCV treatment
Resolute efforts to cure hepatitis C
Multiple stigmas, shame and historical trauma compound the experience of Aboriginal Australians living with hepatitis C
Negotiating access to medical treatment and the making of patient citizenship
| Obras citantes distintas | 7 |
|---|---|
| Citas por año | 1,4 |
| Intervalo de citas | 2021 - 2025 (5) |
| Velocidad de citación | recent |
| Altamente citado | No |
| Tipos de cita | Neutras: 7 |